After working at Institut Gustave Roussy between 1986-2002, Hanna Kafrouni, PhD in Medical Physics, became founder, Chief Executive Officer and President of DOSIsoft. He was specifically involved in the development of the ISOgray Treatment Planning System.

In 2016, Hanna Kafrouni nominated Marc Uszynski as the new Chief Executive Officer to manage our growing company. Still President of our company, Hanna Kafrouni is currently working on ambitious projects involving Big Data, Medical Imaging, and Radiomics, with the aim to improve Cancer treatments.

Our Supervisory Board is composed of Gustave Roussy Transfer representative and 3 independent Directors with extensive experience in the medical and pharmaceutical industries. DOSIsoft is regularly sharing experience and receiving advice from renown Physicists and Radiation Oncologists from French and Belgian centers, as well as scientists from the French Alternative Energies and Atomic Energy Commission (CEA), the French National Institute for computer science and applied mathematics (INRIA), Institut Curie and Gustave Roussy. DOSIsoft also works with and participate in numerous events or programs of the International Atomic Energy Agency (IAEA) in Vienna, Austria.

  • Hanna Kafrouni

    Founder & President
  • Marc Uszynski

    Chief Executive Officer
  • François Husson

    Scientific Director
  • Jean-Christophe Diaz

    R&D Director
  • John Seddo

    Director, Global Customer Services
  • Philippe Lu

    Sales Director (Europe, Asia, Oceania)
  • Jérome Lafon

    Sales Manager (France & Africa)
  • Jean-Elie Kafrouni

    CEO - Americas
  • Xiaolu Chen

    Marketing Manager